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Abstract
Type III secretion systems (T3SSs) are central virulence devices for many Gram-negative
bacterial pathogens of humans, animals & plants. Upon physical contact with eukaryotic
host cells, they translocate virulence-mediating proteins, known as effectors, into them dur-
ing infection. T3SSs are gated from the outside by host-cell contact and from the inside via
two cytoplasmic negative regulators, MxiC and IpaD in Shigella flexneri, which together con-
trol the effector secretion hierarchy. Their absence leads to premature and increased secre-
tion of effectors. Here, we investigated where and how these regulators act. We
demonstrate that the T3SS inner membrane export apparatus protein MxiA plays a role in
substrate selection. Indeed, using a genetic screen, we identified two amino acids located
on the surface of MxiA’s cytoplasmic region (MxiAC) which, when mutated, upregulate late
effector expression and, in the case of MxiAI674V, also secretion. The cytoplasmic region of
MxiA, but not MxiAN373D and MxiAI674V, interacts directly with the C-terminus of MxiC in a
two-hybrid assay. Efficient T3S requires a cytoplasmic ATPase and the proton motive force
(PMF), which is composed of the ΔΨ and the ΔpH. MxiA family proteins and their regulators
are implicated in utilization of the PMF for protein export. However, our MxiA point mutants
show similar PMF utilisation to wild-type, requiring primarily the ΔΨ. On the other hand, lack
of MxiC or IpaD, renders the faster T3S seen increasingly dependent on the ΔpH. There-
fore, MxiA, MxiC and IpaD act together to regulate substrate selection and secretion mode
in the T3SS of Shigella flexneri.
Introduction
Type III secretion systems (T3SSs) are central virulence devices for many Gram-negative bacte-
rial pathogens of humans, animals & plants. They translocate virulence proteins into eukary-
otic host cells to manipulate them during infection. T3SSs are key to the virulence of enteric
pathogens such as E. coli, Salmonella and Shigella species. Bacterial diarrheal illnesses lead to
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~10% of deaths in children<5 yrs in the developing world [1]. Enterobacteriaceae also lead to
serious disease outbreaks in rich societies.
Shigella is the agent of human bacillary dysentery. Its T3SS consists of a cytoplasmic portion
and a transmembrane region traversing both bacterial membranes, into which a hollow needle
is embedded protruding from the bacterial surface [2]. Physical contact with eukaryotic host
cells activates the secretion system, which initiates secretion and leads to formation of a pore,
formed by the bacterial proteins IpaB & IpaC in Shigella, in host-cell membranes [3]. Through
the needle [4] and pore channels, the effectors are translocated to facilitate host cell invasion
[3]. The needle tip complex (TC), which contains IpaD and IpaB, is the host cell sensor and
transforms itself into the translocation pore [5, 6] via addition of IpaC upon secretion activa-
tion [7, 8]. IpaD is hydrophilic and required for tip recruitment of the other two proteins,
which are hydrophobic. Together, they are called the translocators.
Effectors acting late in the host cell manipulation cascade are only expressed once pre-
synthesised early effectors have been secreted at host cell contact, but via differing mechanisms
from one T3SS-carrying organism to another [9]. Yet, one regulatory cascade is conserved, that
allowing hierarchical secretion of substrates [10]. How this cascade functions in animal patho-
gens is the focus of this work. There, effector secretion is initially prevented through concerted
action of surface TC proteins and regulators controlling secretion from within the bacterial
cytoplasm. The TC may prevent premature effector secretion by allosterically constraining the
T3SS in a secretion “off” conformation [11, 12]. Upon physical contact of the TC with host
cells [13], a signal is transmitted via the TC [13] and needle [14] to the cytoplasm where it trig-
gers secretion [11]. Next, translocators are secreted to form the pore in the host membrane.
Successful pore formation at the needle tip generates a second needle-transmitted signal [11,
14, 15], allowing inactivation or T3S-mediated removal of a conserved cytoplasmic regulatory
protein, MxiC in Shigella [16]. Third, early effector proteins are secreted and translocated into
the host cell [11] and expression of late effectors, including the family of ipaH genes [17], is
activated via activation of the transcription factor MxiE [18].
Members of the MxiC family [19] are termed “gate-keepers” as they regulate initial substrate
selection hierarchies. In animal pathogens, all MxiC-class proteins prevent effector secretion in
the absence of an activation signal: whenmxiC or its homologues are deleted, bacteria constitu-
tively secrete effectors [16]. Deletion ofmxiC and some of its homologs also leads to decreased
translocator secretion [11], indicating the proteins can also promote translocator secretion.
The gate-keepers have conserved structures [20, 21]: after an N-terminal secretion signal and
chaperone binding domain (CBD), three α-helical X-bundles form a flat and elongated struc-
ture [21] typical for “hub proteins” regulating processes via interaction with multiple partners.
In some species, gate-keepers are composed of two proteins where the second polypeptide cov-
ers the C-terminal X-bundle (domain 3; [20]).
Several gate-keepers bind heterodimeric intrabacterial chaperones [20, 22] but, no chaper-
one was found in Shigella [16, 23]. Some MxiC homologues also interact with effector proteins
and this can help regulate the secretion hierarchy [24]. However, none of these partners are
conserved, making them unlikely mediators of conserved gate-keepers functions. Instead,
MxiC homologs may control secretion by interacting with the cytoplasmic face of the T3SS
export apparatus (EA), blocking an acceptor site for effectors and/or altering its activity [11,
12, 15, 25, 26].
The conserved EA is composed of 5–6 inner membrane proteins (IMEA) and some periph-
eral/cytoplasmic ones (CEA) (Fig 1A). The latter includes 1–2 “C-ring” components that bind
cytoplasmic IMEA portions and 3 components of an ATPase complex interacting with the
IMEA and C-ring and evolutionarily related to F1Fo-ATPases [27]. F1-ATP synthase’s hex-
americ ring connects to Fo via a central stalk, rotated for catalysis through the ring by proton
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motive force (PMF)-driven rotation of Fo in the membrane. A peripheral stalk connecting F1
and Fo functions as a stator. The flagellum, which also uses a T3SS (fT3SS) to assemble, and
the Pseudomonas and Yersinia virulence mediating T3SS (vT3SS), all use the PMF to catalyse
protein export [28–31]. In the fT3SS, IMEA part(s), including FlhA, function as a proton-pro-
tein antiporter [32], the activity of which is initiated and/or stimulated by the hexameric
Fig 1. Schematic of Shigella T3SS and location of MxiAC mutations altering substrate selection. (A) Shematic of Shigella T3SS. Needle
components in blue-greens, transmembrane base dark purple, IMEA light purple, CEA components (C-ring and ATPase complex) in light blues. A
curved arrow shows the proposed direction of proton flow during protein export, which may be coupled to ATP hydrolysis. Pseudomonas vT3SS and
Salmonella fT3SS homologs mentioned in the text are shown in italics. (B) MxiAC monomer (chain B [36]), putative oligomerisation domain (indicated by
aas with charges shown) facing viewer.Grey, domain 4, facing cytoplasm; light blue, aa involved in chaperone binding within domain 2; mutations in
both of these affect substrate selection in FlhA [44, 45]. Pink, location of mutations found in this work; top rightN373, in an unstructured loop; bottom,
I674.Orange, Q608 and green, location of two activating mutations identified by Rietsch [31] (homologous to Y587 and M667 in PcrD). Mutations in
pink and orange aas are all surface located and affect interaction with MxiC. Right: cyan, chain A of oligomer. Assembly rotated left to showmutations
do not cluster at oligomer interfaces (inside of nonamer ring facing viewer). (D) Schematic presenting the sequence homologies and functional
correspondences between Shigella and Pseudomonas regulatory proteins mentioned in this work. Proteins are presented linearly, from N- to C-
terminus; SS, secretion signal; CBD, chaperone binding domain; XB, X-bundle.
doi:10.1371/journal.pone.0155141.g001
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ATPase FliI [33, 34]. FliI’s activity is coupled to the IMEA’s by FliJ’s interaction with FlhA
[32]. FlhA, known as MxiA in the Shigella vT3SS, is a polytopic membrane protein with a large
C-terminal transmembrane region essential for the secretion process [35], which may form a
nonameric ring within the IMEA [36]. It binds FliJ, Spa13 in the Shigella vT3SS, via an
extended linker region connecting the cytoplasmic region to the membrane [32, 37]. FliJ shows
structural similarity to the rotating subunit of F1Fo-ATPases [38], whilst FliH, probably MxiN
in the Shigella vT3SS, is homologous to their stator region.
The only IMEA components so far involved in substrate selection are those of the FlhB and
FlhA families. In FlhB homologs, an autocleavage/conformational change allows export of the
next appropriate substrates upon base completion [27, 39]. FlhA family proteins suppress pre-
mature export of these substrates [27, 31] and may then selectively stimulate their export [40,
41] (Fig 1B and 1C). Yet, no MxiC homolog was identified in fT3SSs. But, in several vT3SSs, a
MxiC homologue fraction is membrane-associated [24, 42]. In one case, its departure from this
location correlates with effector secretion [26]. MxiC also interacts with the ATPase and the
needle periplasmic rod [15, 16], although its action(s) on them is undefined. In addition, a
“sorting platform” composed of C-ring and ATPase components is selectively “loaded” with
translocators and effectors through action of their chaperones and a MxiC homolog [43].
Recently, Pseudomonas Pcr1, a homolog of MxiC’s domain 3 (Fig 1D), was found to interact
directly with PcrD, an FlhA homolog [31].
MxiC homologues also interact with the hydrophobic translocators’ chaperone, IpgC in
Shigella [15, 42], via a domain 3 site [22, 46]. Furthermore, alteration of IpaD’s self-chaper-
one domain [13] or, in other species, its separately encoded intrabacterial chaperone [12],
upregulates translocator export. As chaperones are not secreted, the latter control gate-
keeper activity intrabacterially [12]. This is supported by genetic dissociation of IpaD’s intra-
cellular and TC regulatory roles [13]. IpaD’s intracellular role also requires MxiC [11, 13].
This suggests all these factors interact intrabacterially to prevent premature translocator
secretion. Indeed, PcrG, the Pseudomonas equivalent of the IpaD self-chaperone domain (Fig
1D), interacts with Pcr1 [31]. Furthermore, MxiC, IpaD, IpgC, IpaB and IpaC interact, albeit
weakly [23].
IpaD removal from the cell increases the secretion rate. ΔipaD is one of only two mutants
identified as a “fast” constitutive secreter in Shigella, the other being ΔipaB [5]. By comparison,
the constitutive secretion observed in ΔmxiC is slower [11]. Lack of IpaB liberates IpgC, a tran-
scriptional co-activator of late effectors genes in Shigella. However, IpaB is present at wild-type
levels in ΔipaD [23], indicating the cause of rapid secretion in ΔipaD lies elsewhere. It may
result from absence of an inhibitory complex containing IpaD associated with the secretion
apparatus. Indeed, Pseudomonas PcrG interacts with PscO, a FliJ/Spa13 homolog, and with
PcrD (FlhA/MxiA), to hinder fast PMF-dependent activity of the EA prior to activation signal
reception, which then requires a rapid secretion burst [31].
Here, we sought to validate the role of PrcD/FlhA homolog MxiA in regulation of substrate
selection and the role of the homologs of proteins known to interact with it in the Pseudomonas
vT3SS and the Salmonella fT3SS, MxiC, IpaD and Spa13 in Shigella, in controlling the secretion
rate. Using a genetic screen, we identified two amino acids located on the surface of MxiA’s
cytoplasmic region (MxiAC) which, when mutated, upregulate late effector expression and
secretion. We find these do not affect PMF-utilization during export but abolish the interaction
of MxiAC with MxiC in a 2-hybrid assay. Using this assay we also mapped the site of interac-
tion with MxiAC to the extreme C-terminus of MxiC. Finally we show that lack of MxiC and
IpaD renders T3S in Shigella increasingly dependent on the ΔpH, rather than on the ΔC com-
ponent of the PMF, suggesting these proteins also regulate a switch in secretion mode.
Regulation of Type III Secretion in S. flexneri
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Methods
Bacterial strains and cell culture
All bacterial strains and plasmids used in this study are listed in Table 1. S. flexneri strains were
maintained and selected on CR agar plates [47] and grown at 37°C in trypticase soy broth
(TCSB; Becton Dickinson) supplemented with antibiotics when necessary (100 μg of ampicillin
ml-1, 50 μg of kanamycin ml-1, 20 μg of chloramphenicol ml-1; Sigma). E. coli strains were
maintained and selected on LB agar plates supplemented with antibiotics when necessary as
for S. flexneri.
Knockout and complementation ofmxiA
In-frame deletion of inner membrane export apparatus protein MxiA was carried out by using
the λ Red system [52]. A kanamycin resistance cassette was amplified from plasmid pKD4
using primersmxiA_KO_kanF andmxiA_KO_kanR and electroporated into S. flexneri wild-
type carrying the Red recombinase to replacemxiA, giving rise to ΔmxiA, which was verified
via sequencing primersmxiA_KO_ver_F andmxiA_KO_ver_R. Complementation was
achieved by in trans expression ofmxiA in the low copy plasmid pWSK29 [53], giving rise
ΔmxiA/mxiA.mxiAmutants were obtained via in-fusion cloning (Clontech) using template
pWSK29mxiA and corresponding primers, such as MxiA_N373D-For and MxiA_N373-
D-Rev, as listed in Table 2. All constructs were verified by DNA sequencing (Eurofins).
MxiA mutant library screening
For reporter plasmid constructionmxiA, followed by two transcription terminators, was
cloned upstream of the reporter gene cepH, which encodes resistance to cephalosporins [54]. A
1485 bp DNA sequence (Figure A in S1 File; [17, 55]), modified from plasmid pQF50 and
encoding two transcription terminators, the minimal promoter of ipaH9.8, and the cepH gene,
flanked by EcoRI and XhoI restriction sites was synthesized by Eurofins and cloned down-
stream ofmxiA in pWSK29 [53]. The resulting plasmid complemented ΔmxiA and the com-
plemented strain was sensitive to 60–120 ng/ml cefotaxime (Sigma) on plates containing CR.
mxiA was then amplified by error-prone PCR with 2.5–5 mMMg++ and Taq DNA Polymerase
(New England BioLabs) using primersmxiA_XbaI_RBS_F andmxiA_EcoRI_R, cloned into
the reporter plasmid, transformed into DH5α to generate a library of MxiA mutants. The size
of the libraries was estimated by plating a portion of the transformation mix on LB Ampicillin
agar plates and the mutation rate was evaluated as 70% of sequences carrying one or more
non-silent single base pair substitutions (predominantly to As and Ts) by randomly sequencing
10 transformants. Based on PEDEL, Programme for Estimating Diversity in Error-prone PCR
Libraries (http://guinevere.otago.ac.nz/cgi-bin/aef/pedel.stats.pl), if we assume the mean num-
ber of point mutations per sequence is 0.7, 54,000 transformants are required to cover 95% of
single point mutations in MxiA. The MxiA mutant libraries were transformed into ΔmxiA and
screened on plates containing 60 ng/ml cefotaxime without CR and 120 ng/ml cefotaxime with
CR, respectively.
PMF inhibition assays
To test the role of the ΔC and ΔpH in Ipa proteins export, we used carbonyl cyanidem-chloro-
phenyl hydrazone (CCCP, Sigma) as previously described [29, 31]. Briefly, cells at mid-log
growth stage were washed twice in TCSB medium (pH ~7.3) containing 120 mM Tris (pH 7.0),
and resuspended in TCSB containing either 0.5% DMSO or CCCP at concentrations up to
40 μM at 37°C for 30 min. To test the role of the ΔC alone, we used valinomycin (Sigma) as
Regulation of Type III Secretion in S. flexneri
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Table 1. Shigella flexneri and E. coli strains used in this study.
Strain Genotype (strain; plasmid) Reference
Shigella ﬂexneri
WT Wild-type M90T, serotype 5a [48]
WT/pHluorin WT; pYVM007 This study and
[49]
ΔipaD SF622 [50]
ΔmxiC WT with deletion of mxiC [11]
ΔmxiA WT with deletion of mxiA This study
ΔmxiA/mxiA ΔmxiA; pWSK29 mxiA This study
ΔmxiA/mxiAN373D ΔmxiA; pWSK29 mxiAN373D This study
ΔmxiA/mxiAQ608R ΔmxiA; pWSK29 mxiAQ608R This study
ΔmxiA/mxiAI674V ΔmxiA; pWSK29 mxiAI674V This study
E. coli KS1 for two-hybrid assay (only fused genes are shown in the plasmid)
Negative control pRA02 pRA03 (pRA02 and pRA03 contain RNAP α
subunit and λ cI, respectively)
[51]
Positive control pRA02 uvrA1-252 pRA03 mfd1-219b [51]
MxiC and MxiAC interaction
MxiC:MxiAC318-686 pRA02 mxiC pRA03 mxiAC318-686 This study
MxiC:MxiAC318-686 N373D pRA02 mxiC pRA03 mxiAC318-686 N373D This study
MxiC:MxiAC318-686 Q608R pRA02 mxiC pRA03 mxiAC318-686 Q608R This study
MxiC:MxiAC318-686 I674V pRA02 mxiC pRA03 mxiAC318-686 I674V This study
MxiC:MxiAC356-686 pRA02 mxiC pRA03 mxiAC356-686 This study
MxiC:MxiAC356-686 N373D pRA02 mxiC pRA03 mxiAC356-686 N373D This study
MxiC:MxiAC356-686 Q608R pRA02 mxiC pRA03 mxiAC356-686 Q608R This study
MxiC:MxiAC356-686 I674V pRA02 mxiC pRA03 mxiAC356-686 I674V This study
MxiC ΔC4:MxiAC356-686 pRA02 mxiC ΔC4 pRA03 mxiAC356-686 This study
MxiC ΔC9:MxiAC356-686 pRA02 mxiC ΔC9 pRA03 mxiAC356-686 This study
MxiC ΔC14:MxiAC356-686 pRA02 mxiC ΔC14 pRA03 mxiAC356-686 This study
MxiAC356-686:MxiC pRA02 mxiAC356-686 pRA03 mxiC This study
IpaD and MxiAC interaction
IpaD:MxiAC318-686 pRA02 ipaD pRA03 mxiAC318-686 This study
IpaD:MxiAC318-686 N373D pRA02 ipaD pRA03 mxiAC318-686 N373D This study
IpaD:MxiAC318-686 Q608R pRA02 ipaD pRA03 mxiAC318-686 Q608R This study
IpaD:MxiAC318-686 I674V pRA02 ipaD pRA03 mxiAC318-686 I674V This study
IpaD:MxiAC356-686 pRA02 ipaD pRA03 mxiAC356-686 This study
MxiAC356-686:IpaD pRA02 mxiAC356-686 pRA03 ipaD This study
Spa13 and MxiAC/IpaD/MxiC interaction
Spa13:MxiAC318-686 pRA02 spa13 pRA03 mxiAC318-686 This study
Spa13:MxiAC318-686 N373D pRA02 spa13 pRA03 mxiAC318-686 N373D This study
Spa13:MxiAC318-686 Q608R pRA02 spa13 pRA03 mxiAC318-686 Q608R This study
Spa13:MxiAC318-686 I674V pRA02 spa13 pRA03 mxiAC318-686 I674V This study
Spa13:MxiAC356-686 pRA02 spa13 pRA03 mxiAC356-686 This study
Spa13:MxiAC356-686 N373D pRA02 spa13 pRA03 mxiAC356-686 N373D This study
Spa13:MxiAC356-686 Q608R pRA02 spa13 pRA03 mxiAC356-686 Q608R This study
Spa13:MxiAC356-686 I674V pRA02 spa13 pRA03 mxiAC356-686 I674V This study
Spa13:IpaD pRA02 spa13 pRA03 ipaD This study
Spa13:MxiC pRA02 spa13 pRA03 mxiC This study
Additional controls
(Continued)
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previously described [29, 31]: cells were washed further in TCSB containing 150 mM KCl after
Tris treatment, then resuspended in TCSB containing 150 mM KCl supplemented with either
0.5% DMSO or valinomycin at concentrations up to 40 μM at 37°C for 30 min. To test the role
of the ΔpH alone, cells were washed twice in 200 mM sodium phosphate buffer, pH 5.85, then
resuspended in the same buffer containing potassium benzoate (Sigma) [56] at concentrations
up to 40 mM at 37°C for 30 min. Both cells and supernatants were collected and analyzed by
immunoblotting using the antibodies indicated in the figures.
Intracellular pH measurement
ShigellaWT was transformed with plasmid pYVM007, which encodes a pH-sensitive, ratio-
metric GFP derivative [49]. The bacteria were cultured overnight in TCSB medium with
100 μg/ml ampicillin, diluted 1:200 into fresh TCSB with 100 μg/ml ampicillin and 0.1 mM
IPTG and grown to mid-logarithmic phase. The bacteria were then pelleted and resuspended
in 200 mM sodium phosphate buffer with different concentrations of potassium benzoate or
valinomycin with 150 mM KCl, and incubated for 30 minutes before measuring the fluores-
cence emission of pHluorin (520 nm emission) excited at 410 and 470 nm using a POLARstar
Omega plate reader spectrophotometer (BMG). A standard curve was established by resus-
pending bacteria in 200 mM sodium phosphate buffer (pH 5.85, 6.34, 6.89, 7.41 and 7.91) in
the presence of 40 mM potassium benzoate, and used to calculate the intracellular pH of the
inhibitor-treated samples. Data is presented as ΔpH compared to the external pH of the buffer
used.
Change of membrane potential
The change in membrane potential of PMF inhibitor-treated S. flexneri was detected using
potential sensitive fluorescent dye DiSC3(5) (Sigma) as previously described [31]. Briefly, the
overnight WT bacteria were diluted 1:200 in fresh TCSB medium and grown to mid-logarith-
mic phase. Cells were pelleted, washed and resuspended in 5 mMHEPES buffer, pH 7.7, to an
Table 1. (Continued)
Strain Genotype (strain; plasmid) Reference
-:MxiAC318-686 pRA02 pRA03 mxiAC318-686 This study
-:MxiAC318-686 N373D pRA02 pRA03 mxiAC318-686 N373D This study
-:MxiAC318-686 Q608R pRA02 pRA03 mxiAC318-686 Q608R This study
-:MxiAC318-686 I674V pRA02 pRA03 mxiAC318-686 I674V This study
MxiAC318-686:MxiAC318-686 pRA02 mxiAC318-686 pRA03 mxiAC318-686 This study
MxiAC318-686 N373D:
MxiAC318-686 N373D
pRA02 mxiAC318-686 N373D pRA03 mxiAC318-686 N373D This study
MxiAC318-686 Q608R:
MxiAC318-686 Q608R
pRA02 mxiAC318-686 Q608R pRA03 mxiAC318-686 Q608R This study
MxiAC318-686 I674V:MxiAC318-
686 I674V
pRA02 mxiAC318-686 I674V pRA03 mxiAC318-686 I674V This study
-:MxiAC356-686 pRA02 pRA03 mxiAC356-686 This study
MxiAC356-686:- pRA02 mxiAC356-686 pRA03 This study
MxiAC356-686:MxiAC356-686 pRA02 mxiAC356-686 pRA03 mxiAC356-686 This study
Spa13:- pRA02 spa13 pRA03 This study
IpaD:IpaD pRA02 ipaD pRA03 ipaD This study
MxiC:MxiC pRA02 mxiC pRA03 mxiC This study
doi:10.1371/journal.pone.0155141.t001
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OD600 of 0.1 supplemented with 0.4 μMDiSC3(5) dye. Cells were incubated at room tempera-
ture for 20 minutes, at which point 100 mM KCl (final concentration) was added. The cells
were then treated with potassium benzoate or valinomycin and incubated for an additional 30
minutes. Increase in DiSC3(5) fluorescence due to the disruption of the membrane potential
gradient (ΔC) was detected using a POLARstar Omega plate reader spectrophotometer (BMG,
excitation 620 nm, emission 670 nm). Data is presented as fold change in fluorescence intensity
relative to wild-type bacteria without inhibitor treatment.
Analysis of Ipas secretion and protein expression
The secretion of Ipa proteins after Congo red induction was carried our as previously described
[11]. The total level of protein expression was revealed via western blot using monoclonal anti-
IpaB H16 [57] and polyclonal anti-IpaH [58], anti-RNAP α subunit (gift from Prof. Akira Ishi-
hama, Hosei University, Koganai, Tokyo) and anti-λ cI (gift from Prof. Ann Hochschild, Har-
vard Medical School, Boston). Goat anti-mouse DyLight 800 (Fisher Scientific) or goat anti-
rabbit Alexa 680 (Invitrogen) conjugates were used as secondary antibodies. The membranes
were then visualized using an Odyssey infrared imaging system (LI-COR Biosciences).
Table 2. Primer sequences used in this study.
Primer Sequence
Primers to knock out mxiA and veriﬁcation of ΔmxiA
mxiA_KO_kanF 5’-GTGCATACAAGAAAGAGCTTTCTAGATAACAGGAGATAAAAGTGATCCAGTCTTTTGTGTAGGCTGGAGCTGCTTC-3’
mxiA_KO_kanR 5’-TAACTAATTGAACTAAATTAATGTTACTCATATTTAAACCTCACTAAATAGTCTTTAACATATGAATATCCTCCTTAG-3’
mxiA_KO_Ver_F 5’-GCCAGTCATGAGGATTCTGTAG-3’
mxiA_KO_Ver_R 5’- TGGTAATCGCTGAATGGCTG-3’
Primers for PCR mutagenesis of mxiA
mxiA_XbaI_RBS_F AGTCTCTAGAAGATAACAGGAGATAAAAGTGATC
mxiA_EcoRI_R AGTCGAATTCTAAATAGTCTTTAATACAT
Primers to make fusion proteins into pRA02 and pRA03
IpaD_NheI_For 5’-GCGCGCTAGCAATGAATATAACAACTCTGACTAATAG-3’
IpaD_KpnI_Rev 5’-GCGCGGTACCTCAGAAATGGAGAAAAAGTTTATC-3’
MxiAC318_XbaI_3G_For 5’-AGTCTCTAGAaggtggaggGGTCGTAGAAAAAGAAAAAAG-3’
MxiAC356_XbaI_3G_For 5’-AGTCTCTAGAaggtggaggTATTAGTTCAGAAACCGTTC-3’
MxiA_KpnI_Rev 5’-AGTCGGTACCCTAAATAGTCTTTAATACA-3’
MxiC_NheI_For 5’-GCGCGCTAGCAGAGCTCATGCTTGATGTTAAAAATACAG-3’
MxiC_KpnI_Ror 5’-GCGCGGTACCGGATCCTTATCTAGAAAGCTCTTTCTTG-3’
Spa13_XbaI_3G_For 5’-AGTCTCTAGAaggtggaggGAAACAATTAGATAAGG-3’
Spa13_KpnI_Rev 5’-AGTCGGTACCTTATCTAATGCCATACTTC-3’
Primers for in-fusion cloning
MxiA_N373D-For 5’-GAAAATAAGATAgATGCAAATG-3’
MxiA_N373D-Rev 5’-GCATcTATCTTATTTTCGGC-3’
MxiA_Q608R-For 5’-AGGGATAAGGCgAACCTCTG-3’
MxiA_Q608R-Rev 5’-GGTTcGCCTTATCCCTTTTC-3’
MxiA_I674V-For 5’-CGTATGCTGAGgTTGATGAAG-3’
MxiA_I674V-Rev 5’-CAAcCTCAGCATACGATATAACG-3’
MxiC_IF_For 5’-TAAGGATCCGGTACCCTAGAG-3’
MxiC_IF_delC4_Rev 5’-GGTACCGGATCCTTATTTCTTGTATG-3’
MxiC_IF_delC9_Rev 5’-GGTACCGGATCCTTATGTGACAAG-3’
MxiC_IF_delC14_Rev 5’-GGTACCGGATCCTTATAGAATATTG-3’
doi:10.1371/journal.pone.0155141.t002
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Bacterial two-hybrid assay
The bacterial 2-hybrid assay used in this work is essentially that developed by Dove and Hochs-
child [59]. Reporter strain E.coli KS1, which carries a chromosomal lacZ gene under the control
of a lac promoter placOR2-62, can be activated by interactions between a protein fused to λ cI
and a protein fused to the RNA polymerase (RNAP) α subunit. To generate the plasmids,
genes to-be-fused were PCR amplified using primers listed in Table 2, double digested with
KpnI and XbaI (formxiA and spa13) or NheI (for ipaD andmxiC), and then ligated into plas-
mids pRA02, which encodes RNAP α subunit and pRA03, which encodes λ cI [51], both dou-
ble digested with KpnI and XbaI (producing an overhang compatible with NheI). For genes
with mutations to-be-fused, such asmxiAC356-686 N373D, in-fusion cloning (Clontech) was per-
formed using either pRA02 or pRA03mxiAC356-686 N373D as PCR template via primers
MxiA_N373D-For and MxiA_N373D-Rev. All primers are listed in Table 2 and all constructs
were verified by DNA sequencing (Eurofins). E.coli KS1 cells were transformed with the combi-
nations of pRA02 and pRA03 derivatives listed in Table 1. An overnight culture was diluted
and grown to mid-log phase (A600 0.3~0.5) in LB broth supplemented with IPTG (1 mM) and
antibiotics. β-galactosidase activity was assayed as described by Miller [60].
Results
MxiA double mutant displays increased expression of the IpaH family of
late effectors
To identify mutation(s) involved in intracellular activation of the Shigella T3SS, we constructed a
reporter plasmid where the cefotaxime resistance gene cepH [54] is under the control of the mini-
mal promoter of the late effector gene ipaH9.8 [17]. The expression of ipaH9.8 is only turned on
upon T3SS activation. Hence, we can select for mutants leading to ipaH9.8 expression via
pipaH9.8 cepH-dependent generation of resistance to cefotaxime. We used this plasmid, where
mxiA followed by transcription terminators was cloned upstream of pipaH9.8 cepH, to screen for
mxiAmutants leading to cefotaxime resistance in a ΔmxiA background. As MxiA is an essential
component of the T3SS CEA, only gain-of-functionmxiAmutants can be returned by the screen
since those that disrupt function will not answer the selection. Amongst an estimated 5000 trans-
formants, which cover about 20% of potential single mutation of MxiA in our screening, we iden-
tified one cefotaxime-resistant transformant, which bears two mutations: N373D and I674V. The
need to use a low copy plasmid for complementation and as a reporter limited the transformation
and hence screening efficiency, making it impractical to seek to saturate the screen. The mutant
showed 2 to 3 fold increased expression of IpaH proteins compared to WT and ΔmxiA/mxiA
(Figure B, panel a in S1 File). To further understand the role of each of these mutations, we con-
structed ΔmxiA/mxiAN373D and ΔmxiA/mxiAI674V. For comparison, we also made ΔmxiA/
mxiAQ608R based on a recent publication [31], which identified PcrDQ626R, which is homologous
to MxiAQ608R, as resulting in activation of effector secretion under normally repressive condi-
tions in Pseudomonas aeruginosa. The location of the three mutations is shown in Fig 1B and 1C:
they are all on the surface of the globular C-terminal domain of the protein. I674 lies quite close
to Q608 on the bottom (cytoplasm-facing) part of the inner face while N373 lies in an unstruc-
tured loop on the upper (membrane-facing) part of the outer face of the putative nonameric ring.
MxiAI674V behaves similarly to WT but secretes more late effector protein
IpaH relative to early effector IpaB
To understand the effect of these MxiA mutations, we carried out functional assays of T3SS
activity, including Congo red (CR) induction and overnight leakage. “Induction” describes the
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burst of Ipa protein secretion upon host cell sensing [61] or addition of the artificial inducer
CR [62]. “Overnight leakage” is a slow, low-level Ipa protein secretion prior to host cell contact
whereby around 5% of Ipa proteins are secreted [63]. With respect to CR induction (Fig 2A),
ΔmxiA/mxiAN373D, ΔmxiA/mxiAQ608R and ΔmxiA/mxiAI674V all behaved like the wild-type
and ΔmxiA/mxiA. In contrast, the ΔmxiA was uninducible by CR due to the lack of a functional
T3S apparatus, and ΔipaD was insensitive to CR because it lacks a tip complex [5] and is a
known constitutive secretor [64]. In comparison to wild-type and complemented strains, all
mutants showed similar expression levels of later effectors IpaH relative to the early effector
IpaB (Fig 2B and Figure C, panel a in S1 File). No differences were observed between any
mutants and the complemented strain for the secretion level of IpaH relative to its expression
Fig 2. MxiAI674V mutant behaves similarly to WT but secretes more late effector protein IpaH relative to early
effector IpaB. (A) Induced secretion of Ipa proteins after the addition (+) or in absence (-) of Congo red (CR) was
analysed by silver staining. The positions of the major Ipa proteins detected are indicated on the right side. (B)
Overnight total culture (top) and supernatant (bottom) were analysed by immunoblotting using antibodies against
translocator IpaB or later effector IpaH as indicated. Bacterial numbers were normalized by OD600 and the data
shown here are representative of three independent experiments giving similar results. (C) Secretion level of IpaH
relative to the secretion level of IpaB inmxiAmutants adjusted to complemented strain whose ratio was set as
100%. Statistical analysis was performed using R (https://www.R-project.org/). The statistical significance of the
differences compared with the control is noted based on four experiments: *p = 0.021, Wilcoxon test; p = 0.078,
Welch two samples t-test.
doi:10.1371/journal.pone.0155141.g002
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nor for the secretion level of IpaB relative to its expression (Figure C, panels b & c in S1 File).
However, MxiAI674V secreted more later effectors IpaH relative to the early effector IpaB
compared with the complemented strain, although the statistical significance of the difference
observed was marginal (Fig 2C). This is similar, if less drastic as might be expected from the
subtler nature of the mutations involved, to what was previously reported for ΔmxiC (Fig 2C;
[11]). Taken together, these data suggest that at least amino acid I674 within MxiA is involved
in regulating the secretion switch between early and later effectors.
The MxiAI674V mutant andWT respond similarly to PMF inhibitors, but
ΔmxiC and ΔipaD respond differently
Evidence has been provided that protein export via flagellar and virulence T3SSs relies partly
on the PMF across the bacterial inner membrane as an energy source, which may be utilized by
MxiA homologs [29–32, 65, 66]. If themxiAmutants we isolated allow the Shigella T3SS to use
the PMFmore efficiently, then these mutations should render the export process more resistant
to the collapse of the PMF. Therefore, we tested the ability of ourmxiAI674V mutant to modu-
late the sensitivity of translocator export to the addition of PMF inhibitors, as compared to
WT, ΔmxiC and ΔipaD.
The PMF consists of two components, an electric potential difference between the periplas-
mic and cytoplasmic faces of the membrane (ΔC) and a proton concentration difference (ΔpH).
CCCP functions as an ionophore to discharge both ΔC and ΔpH [29], valinomycin shuttles
potassium into the cell, thereby balancing the difference in charge and collapsing the ΔC [29],
while benzoic acid is a membrane-permeant weak acid which can enter the cell and collapse the
ΔpH of the PMF when added in a low external pH environment [67]. In TCSB medium, IpaB
secretion was strongly inhibited by 10 μMCCCP in all strains (Fig 3A and Figure D in S1 File).
Potassium benzoate, but not valinomycin/KCl, disrupts the ΔpH in Shigella at external pH 5.85
(Figure F, panels a & b in S1 File), but not at external pH above 7 (not shown) or in TCSB
medium due the changing external pH therein (Figure G in S1 File). While 20 mM potassium
benzoate dramatically inhibited IpaB secretion in ΔipaD and to a lesser extent in ΔmxiC, it had
no effect on the secretion of IpaB inWT ormxiAI674V (Fig 3B and Figure E in S1 File). Valino-
mycin/KCl, but not potassium benzoate, collapses the ΔC (Figure F, panels c & d in S1 File).
While valinomycin/KCl inhibits the secretion of IpaB in both wild-type andmxiAmutants at
20 μM, ΔipaD is totally resistant to valinomycin up to 40 μM and ΔmxiC is intermediately-resis-
tant to the effect of this drug (Fig 3C and Figure H in S1 File). Thus, WT and ourmxiAmutants
use the PMF similarly, and primarily the ΔC, to secrete translocator IpaB. Interestingly, how-
ever, lack of either of two regulators, MxiC or IpaD, the homologs of which were recently shown
to interact with the MxiA homolog PcrD in Pseudomonas [31], renders IpaB secretion increas-
ingly dependent on the ΔpH, but independent of the ΔC.
ThemxiAmutants no longer interact with MxiC
To determine the reason(s) why our MxiA mutants secrete IpaH proteins more efficiently, we
set-up two-hybrid assays to test if they interact with their potential partners differently. PcrD, a
homologue of MxiA, co-precipitates with Pcr1 [31], which corresponds to C-terminal domain 3
of MxiC. To test the interaction between the C-terminus of MxiA (MxiAC) and MxiC, MxiAC
was fused to λ cI, and MxiC was fused to RNAP α subunit as described in the Materials and
Methods. Interaction-dependent recruitment of RNA polymerase to the promoter leads to the
expression of β-galactosidase, of which the activity was monitored. MxiC interacts strongly with
MxiAC356-686, but not when it is fused to λ cI and MxiAC to RNAP α subunit It also does not
interact with MxiAC318-686 in either fusion configuration (Fig 4A and not shown). The latter
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constructs encode the whole cytoplasmic domain, including what is probably an extended linker
region linking it to its transmembrane region [36]. Therefore, the linker region may regulate the
MxiC-MxiA interaction assessed here. Yet, lack of binding in the presence of a more complete
MxiA construct is a negative result and what we remove is a flexible linker, the conformation of
which can not be assumed to be native in the two-hybrid fusion protein. However, although all
constructs showed similar expression levels of fusion proteins (Fig 4B), RNAP α subunit-MxiC
does not interact with λ cI-MxiAC356-686 bearing mutations N373D, Q608R or I674V. PcrDQ626R
showed reduced interaction with Pcr1 [31]. Thus our data indicate that mutations MxiAQ608R
or nearby MxiAI674V lead to a similar defect, and one that is caused also by the more distantly
Fig 3. MxiAmutants andWT respond similarly to PMF inhibitors, but ΔmxiC and ΔipaD respond
differently. Bacteria were treated with CCCP in TCSBmedium (A), or potassium benzoate in 200 mM sodium
phosphate buffer, pH 5.85 (B), or valinomycin in the presence of 150 mM KCl in TCSBmedium (C) and T3SS-
mediated log-phase “leakage” was analysed. The cell (left) and supernatant (right) fractions were analysed by
immunoblotting using antibodies against translocator IpaB. Bacterial numbers were normalized by OD600 and
the data shown here are representative of 2 or 3 independent experiments giving similar results.
doi:10.1371/journal.pone.0155141.g003
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Fig 4. MxiAmutants no longer interact with MxiC in a bacterial two-hybrid assay.MxiC and its C-terminal
deletion derivatives were fused to RNAP α subunit in plasmid pRA02, and MxiAC and its mutants were fused to
λ cI in plasmid pRA03. Interaction between the fusion proteins recruits RNAP to the lacZ reporter construct,
and β-galactosidase activity reflects the strength of the interaction (A). ‘‘-” indicates the expression of RNAP α
subunit or λ cI only, UvrA1-252 interact with Mfd1-219b [51] and was used as a positive control. Production of
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located mutation MxiAN373D. In parallel, we also sought to map the site of interaction of MxiC
onMxiAC using two-hybrid assays. Consistent with the fact that Pcr1 is homologous the C-ter-
minal quarter of MxiC, although all constructs are expressed (Fig 4B), MxiC with C-terminal
deletions of its last four to fourteen amino acids lost the ability to bind MxiAC356-686.
The work of Lee & Rietsch in Pseudomonas [31] showed that PscO, the homologue of Shi-
gella Spa13, and PcrG, the homologue of the N-terminus of IpaD, interact with PcrD, the
MxiA homologue. Furthermore, they found that PcrG and Pcr1 interact. The interaction of
PcrG & PcrD and PcrG & Pcr1 were shown to be direct, while Minamino et al. showed the FliJ,
the Spa13 homolog, binds FlhA, the MxiA homolog directly [32, 37]. Therefore, we further
checked for interactions between MxiAC (both with and without linker region and as RNAP α
subunit or λ cI fusions, except in combination with the spa13 fusion, where only RNAP α sub-
unit-Spa13 and λ cI-MxiAC could be obtained; Table 1), Spa13, MxiAC and IpaD. However, no
interaction was detected for any of these pairs (data not shown). In this work and previous
work, we also tested for IpaD-MxiC interactions in this assay, also without success [23].
Discussion
In this work, we demonstrate that the Shigella T3SS inner membrane protein MxiA plays a role
in substrate selection. We also show that MxiC and IpaD, two cytoplasmic regulators already
shown to play a role in secretion hierarchy control and to negatively regulate the secretion rate,
also control the export apparatus’ mode of PMF utilization. Finally, we also show that the cyto-
plasmic region of MxiA interacts directly with MxiC and identify residues important for this
interaction in both proteins.
OurmxiAmutants stimulate expression and secretion of some proteins of the IpaH late
effector family, but not of the translocator IpaB. The pcrDQ626R mutant upregulates expression
of the ExoS effector, but its full secretion profile was not shown by Lee & Rietsch [31]. Interest-
ingly, the pcrGΔ30–40,Δ60–70 and the pscOG78E or E88K mutants they characterised have a different
phenotype: they affect mainly the secretion rate, not its specificity [31]. Thus, the cytoplasmic
complex formed around MxiA/PcrD is a major substrate selection point.
As expected from the genetic screen we used to isolate them, the mutations in MxiA that
affect substrate selection are very mild and do not affect the other, essential function(s) of the
protein in T3S. Unlike the partial loss-of-function prcG and pscOmutants described by Lee &
Rietsch (2014), our MxiA point mutants also do not affect PMF utilisation by the T3SS. The
latter was not tested by these authors but as we made a homologous mutant (MxiAQ608R) to
the strongest one they found in PcrD, we assume this is also the case in Pseudomonas. Interest-
ingly, however, each of our point mutants leads to complete loss of interaction with MxiC in
our 2-hybrid assay but PcrDQ626R leads only to a partial loss of interaction with Pcr1 in pull-
downs [31]. This suggests other factors can stabilise this interaction in vivo, although we could
not detect the ones we expected from the work of Lee & Rietsch (2014) in our 2-hybrid assays.
This may be because of slight differences in the assays used or in the cloning of the fusion pro-
teins. More interestingly, this may also be due to differences in how some of these proteins are
found at steady state. Indeed, MxiC is equivalent to PopN and Pcr1, and this complex may a
have different conformation [20] to that of MxiC [21], whereas IpaD is equivalent to PcrV and
PcrG, meaning it may not have its relevant surfaces available for interaction with MxiC. Might
such differences influence the fine-tuning of this regulatory cascade in each species?
the indicated RNAP α subunit and λ cI-fusion proteins was analysed by immunoblotting using antibodies
against RNAP α subunit (B) and λ cI (C). Bacterial numbers were normalized by OD600 and the data shown
here are representative of 2 independent experiments giving similar results.
doi:10.1371/journal.pone.0155141.g004
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On the other hand, lack of the MxiC extreme C-terminus which, according to the MxiC
crystal structure [21], is unlikely to affect its folding dramatically and which causes loss of
MxiA binding in the 2-hybrid assay, is a complete loss-of-function mutant in Shigella [23, 68].
While relatively conservative substitutions are likely less disruptive than short deletions, this
suggests that the site targeted by the MxiC C-terminus on MxiA is important to formation of
this regulatory complex. Although we have insufficient information to dock the MxiAC and
MxiC structures together, the location of our MxiA mutants suggest MxiC may wrap around
the MxiA nonamer, from the outside to the inside of the ring.
How our MxiA mutations act to upregulate ipaH gene expression is not clear. Our mutants
do not demonstrate detectably increased “leakage” (Figure B, panel b in S1 File). Therefore,
this slight upregulation is unlikely to be occurring via the previously characterised MxiE tran-
scriptional activator. This protein requires its co-activator, IpgC, the cytoplasmic chaperone of
IpaB and IpaC translocators, to have been liberated from these by their secretion to interact
with MxiE [58]. Interestingly, amxiCmutant shows a 2-fold decrease in number of T3SSs/cell
[11]. This suggests it is required as a positive regulator of T3SS gene expression. In addition,
one component of the heterodimeric chaperone complex of the ChlamydiaMxiC homolog
CopN acts as an inhibitor of RNA polymerase by binding to its σ66 subunit, when not part of
the CopN complex [69, 70]. Therefore, a role for the MxiA-MxiC interaction in regulating late
effector transcription/translation cannot be excluded. However, that our MxiA mutations do
mildly alter substrate selection is supported by the fact that all but one of the mutations isolated
by Lee & Rietsch [31] and ourselves localise to MxiA/PcrD domain 4 (Fig 1B and 1C), the
main domain involved in substrate selection in their flagellar homolog FlhA [44, 45].
In the Pseudomonas vT3SS, both components of the PMF were required to power transloca-
tor export [31]. In Pseudomonas, a partial defect in PcrG (the homolog of IpaD’s N-terminus)
was shown to render their secretion of translocators more resistant to dissolution both of the
ΔC and of the ΔpH, suggesting they can use these more efficiently [31]. But, in the Salmonella
fT3SS, only the ΔC is required to support flagellar protein export in wild-type cells [65], as we
see here for wild-type Shigella vT3SS and our MxiA mutants also. However, in a Salmonella
fT3SS mutant lacking flagellar ATPase complex and carrying a bypass point mutation (P28T)
in FlhB -the Spa40 homolog- which enhances protein export, Minamino et al. (2011) observed
a dual requirement for ΔC and the ΔpH [32]. The latter is reminiscent of the requirements we
see here for the ΔmxiCmutant, while the ΔipaDmutant, which has the most accelerated secre-
tion rate, requires only the ΔpH. This suggests that the observation made by Minamino et al.
also applies to circumstances where the ATPase complex is present and the IMEA is intact and
that MxiC and IpaD negatively regulate the rate of protein export by controlling the mode in
which MxiA utilizes the PMF. Thus, once again, our data suggest this functional and regulatory
pathway is at least partially conserved, and hence of importance, amongst T3SSs. However,
how MxiAI674 is altered in substrate secretion selection and howWT, ΔmxiC and ΔipaD use
the PMF differently need further investigation.
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